Evidence Library
Filter by drug, type, year, and open access.
Showing 201–250 of 427 results
- Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial — JAMA Network Open (2019)• Drug: lemborexantOpen accessDOIPMIDPMCID
- FDA boxed warning for serious injuries caused by complex sleep behaviors with certain prescription insomnia medicines — FDA Drug Safety Communication (2019)• Drug: zaleplonOpen access
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: methylphenidateDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: dexmethylphenidateDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: amphetamine-dextroamphetamineDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: lisdexamfetamineDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: atomoxetineDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: guanfacine-erDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: clonidineDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: clonidine-erDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: guanfacineDOI
- Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders — Neurology (PMC) (2019)• Drug: pimozideOpen accessDOIPMIDPMCID
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression — American Journal of Psychiatry (2019)• Drug: esketamineDOI
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: viloxazineDOI
- A randomized study of solriamfetol for excessive sleepiness in narcolepsy — Annals of Neurology (2019)• Drug: solriamfetolDOIPMID
- Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial — American Journal of Respiratory and Critical Care Medicine (2019)• Drug: solriamfetolDOIPMID
- Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies — Neuropsychiatric Disease and Treatment (2019)• Drug: aripiprazole-monohydrateOpen accessDOIPMIDPMCID
- Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal(®) Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil — Therapeutic Advances in Psychopharmacology (2019)• Drug: aripiprazole-lauroxilOpen accessDOIPMIDPMCID
- Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016-March 2019 — Current Psychiatry Reports (2019)• Drug: risperidone-perserisDOIPMID
- Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial — Journal of Addiction Medicine (2019)• Drug: lofexidineOpen accessDOIPMIDPMCID
- The Role of Lofexidine in Management of Opioid Withdrawal — Pain Therapy (2019)• Drug: lofexidineOpen accessDOIPMIDPMCID
- Tranylcypromine for treatment-resistant depression: clinical considerations — Journal of Affective Disorders (2019)• Drug: tranylcypromineDOI
- Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development — CNS Drugs (2019)• Drug: zuranolonePMID
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: clozapineOpen access
- Comparative efficacy of antidepressants: network meta-analysis including bupropion — The Lancet (2018)• Drug: bupropionDOIPMID
- Benzodiazepines for catatonia: systematic review and meta-analysis — Schizophrenia Research (2018)• Drug: clonazepamDOI
- Paliperidone palmitate long‑acting injection: efficacy and safety (review) — Review (2018)• Drug: paliperidone
- Risperidone efficacy in schizophrenia: meta‑analysis — Meta‑analysis (2018)• Drug: risperidone
- QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. — Psychosomatics (2018)• Drug: ziprasidoneDOIPMID
- Comparative efficacy of antidepressants: network meta-analysis including citalopram — The Lancet (2018)• Drug: citalopramDOIPMID
- CANMAT and ISBD 2018 guidelines for the management of patients with bipolar disorder. — Bipolar Disorders (2018)• Drug: valproateOpen accessDOIPMIDPMCID
- Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective — Expert Review of Neurotherapeutics (2018)• Drug: valbenazineDOI
- Eszopiclone for insomnia (Cochrane Review) — Cochrane Database of Systematic Reviews (2018)• Drug: eszopicloneOpen accessDOIPMIDPMCID
- Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans — New England Journal of Medicine (2018)• Drug: prazosinDOIPMID
- Gabapentin and Pregabalin for the Treatment of Anxiety Disorders — Clinical Pharmacology in Drug Development (2018)• Drug: gabapentinDOI
- Gabapentin and Pregabalin for the Treatment of Anxiety Disorders — Clinical Pharmacology in Drug Development (2018)• Drug: pregabalinDOI
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: methylphenidateOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: methylphenidateDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: dexmethylphenidateOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: dexmethylphenidateDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: amphetamine-dextroamphetamineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: amphetamine-dextroamphetamineDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: lisdexamfetamineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: lisdexamfetamineDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: atomoxetineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: atomoxetineDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: guanfacine-erOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: guanfacine-erDOIPMID
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: clonidineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: clonidineDOIPMID